Hello and welcome to the details of Asia accelerates AstraZeneca Covid-19 vaccine rollouts, even as trust plunges in Europe and now with the details
Subscribe to our Telegram channel for the latest updates on news you need to know.
TAIPEI, March 22 — Many Asian countries are accelerating the rollout of AstraZeneca’s Covid-19 vaccine after confidence in its safety was hit, following reports that the shot was linked to rare blood clots in Europe earlier this month.
After briefly halting its use, many European countries have resumed using the shot in their inoculation programmes after a regional regulator said it was safe, while several country leaders are also taking the vaccine to boost confidence.
The AstraZeneca shot was among the first and cheapest of the Covid-19 vaccines to be developed and launched at volume and is set to be the mainstay of vaccination programmes in much of the developing world.
But its brief suspension raised concerns that a slowdown in vaccination rollouts could hurt the global fight against the pandemic, as coronavirus cases surge in some countries, overwhelming healthcare systems and hurting economies.
“I have just finished getting the (AstraZeneca) injection, there is no pain at the injection site, and there is no soreness of the body,” Taiwan Premier Su Tseng-chang told reporters as the island launched its inoculation campaign today.
Thailand’s prime minister also became the first person in the country to be inoculated with the AstraZeneca vaccine after its rollout was temporarily put on hold over safety concerns, while Indonesia began using it today after suspending it last week. But Indonesia’s Food and Drug agency has warned against its use on people with blood clotting disorders.
South Korean President Moon Jae-in, 68, plans to get the shot tomorrow after the government said it could be used on older people.
British Prime Minister Boris Johnson received his first dose of the AstraZeneca Covid-19 vaccine on Friday, saying he “did not feel a thing.”
The European Medicines Agency regulator said on Thursday the vaccine is effective and not linked with a rise in the overall risk of blood clots.
Yet a survey released today showed that people in seven European countries were more likely to see the vaccine as unsafe than as safe.
Many Asian countries heavily rely on the AstraZeneca vaccine to end the pandemic, as the shot is being used in inoculation programmes in Australia, South Korea, the Philippines, Vietnam, Thailand, and India.
Some countries could face supply issues.
India, which has the highest coronavirus caseload after the United States and Brazil, is delaying supplies of the vaccine to several countries, as it faces a second surge in cases, said a source with direct knowledge of the matter.
The Serum Institute of India (SII), which produces the AstraZeneca vaccine, has told Brazil, Saudi Arabia and Morocco that further supplies will be delayed due to surging demand at home, the person said.
Australia, which has inoculated just one per cent of its population so far, is also accelerating vaccination after the country’s pharmaceutical regulator approved yesterday the local manufacturing of the AstraZeneca vaccine by CSL.
Within 12 weeks, CSL is expected to produce one million doses of the vaccine each week. — Reuters
These were the details of the news Asia accelerates AstraZeneca Covid-19 vaccine rollouts, even as trust plunges in Europe for this day. We hope that we have succeeded by giving you the full details and information. To follow all our news, you can subscribe to the alerts system or to one of our different systems to provide you with all that is new.
It is also worth noting that the original news has been published and is available at Malay Mail and the editorial team at AlKhaleej Today has confirmed it and it has been modified, and it may have been completely transferred or quoted from it and you can read and follow this news from its main source.